Europe’s largest independent cannabis company
Cannabis-based products for medical use
Thanks to deep scientific expertise, rigorous process management and quality control, EMMAC ensures MHRA medical-grade quality products with the full accreditation of relevant regulatory certifications for its manufacturing, distribution and supply processes.
In partnership with leading European academic institutions including Imperial College London, EMMAC is at the forefront of research to deliver clinical data regarding the efficacy of medical cannabis for pain and the potential health benefits for patients.
At EMMAC Life Sciences Group, we control the entire lifecycle of our medical cannabis – from cultivation and extraction to production and distribution.
People & expertise
EMMAC’s board and management team comprise of seasoned industry executives and consultants. Every member brings with them a wealth of knowledge and experience – from a range of scientific, medical, technical and FMCG backgrounds.
EMMAC announces pioneering research collaboration with Imperial College London
EMMAC Across Europe
EMMAC has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also a European leader in the production and supply of medical cannabis, hemp and other derivative products.
London 27 July 2021 – Curaleaf International (formerly EMMAC Life Sciences Group), (“Curaleaf International”), Europe’s largest vertically integrated cannabis company,
Curaleaf International exports over a ton of medical cannabis flower to Israel; one of the first companies to do so under new regulatory regime
London 8 July 2021 – Curaleaf International (formerly EMMAC Life Sciences Group) (“Curaleaf International”), Europe’s largest vertically integrated cannabis company,
Milestone for Medalchemy in Spain; facility now fully licensed to import, cultivate, extract, manufacture and export medical cannabis flower and
Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership
London 29th June 2021 – Curaleaf International (formerly EMMAC Life Sciences Group), Europe’s largest vertically integrated cannabis company, is pleased
11 May 2021, London. Curaleaf International (formerly EMMAC Life Sciences Group), Europe’s largest vertically integrated cannabis company, is pleased to
27 April 2021, London. Further to the announcement on 26 April 2021 that it received validation from the European Commission
Fill in the form below to receive the latest news and developments in medical cannabis from EMMAC